Death following recreational use of designer drug "bath salts" containing 3,4-Methylenedioxypyrovalerone (MDPV). - Wikidata - wikimedia - TriplyDB

Death following recreational use of designer drug "bath salts" containing 3,4-Methylenedioxypyrovalerone (MDPV).

Death following recreational use of designer drug "bath salts" containing 3,4-Methylenedioxypyrovalerone (MDPV).

http://www.wikidata.org/entity/Q36548946

about

Legal highs: staying on top of the flood of novel psychoactive substances Cathinone neurotoxicity ("The "3Ms")Effects of social interaction and warm ambient temperature on brain hyperthermia induced by the designer drugs methylone and MDPV.NPS: Medical Consequences Associated with Their Intake In vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity.Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology.Use of synthetic cathinones and cannabimimetics among injection drug users in San Diego, California Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine, and product quantification.Toxicity and death following recreational use of 2-pyrrolidino valerophenone.Behavioral pharmacology of designer cathinones: a review of the preclinical literature Baths salts, spice, and related designer drugs: the science behind the headlines.The availability and depiction of synthetic cathinones (bath salts) on the Internet: Do online suppliers employ features to maximize purchases?Acute Methylenedioxypyrovalerone Toxicity.3,4-Methylenedioxypyrovalerone (MDPV): in vitro mechanisms of hepatotoxicity under normothermic and hyperthermic conditions.Comprehensive review of the detection methods for synthetic cannabinoids and cathinones.Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats 4-Methoxy-α-PVP: in silico prediction, metabolic stability, and metabolite identification by human hepatocyte incubation and high-resolution mass spectrometry.Psychoactive "bath salts": not so soothing.Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products "Bath salts" and "plant food" products: the experience of one regional US poison center.Sensitization to the motor stimulant effects of 3,4-methylenedioxypyrovalerone (MDPV) and cross-sensitization to methamphetamine in rats Synthetic cathinone abuse State-dependent and environmental modulation of brain hyperthermic effects of psychoactive drugs of abuse.Intoxications associated with agitation, tachycardia, hypertension, and Fever: differential diagnosis, evaluation, and management.The Reinforcing and Rewarding Effects of Methylone, a Synthetic Cathinone Commonly Found in "Bath Salts"Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death.Individual Differences in the Relative Reinforcing Effects of 3,4-Methylenedioxypyrovalerone under Fixed and Progressive Ratio Schedules of Reinforcement in Rats.Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication.Synthetic cathinones (bath salts): legal status and patterns of abuse.Khat and synthetic cathinones: a review.Synthetic cathinones ("bath salts").Toxicology and management of novel psychoactive drugs.Exposures to conducted electrical weapons (including TASER® devices): how many and for how long are acceptable?Bath Salt-Induced Psychosis: Nursing Assessment, Diagnosis, Treatment, and Outcomes.Comparing rewarding and reinforcing properties between 'bath salt' 3,4-methylenedioxypyrovalerone (MDPV) and cocaine using ultrasonic vocalizations in rats.Synthetic cathinone pharmacokinetics, analytical methods, and toxicological findings from human performance and postmortem cases.Prediction of designer drugs: synthesis and spectroscopic analysis of synthetic cannabinoid analogues of 1H-indol-3-yl(2,2,3,3-tetramethylcyclopropyl)methanone and 1H-indol-3-yl(adamantan-1-yl)methanone.Atypical dopamine efflux caused by 3,4-methylenedioxypyrovalerone (MDPV) via the human dopamine transporter.

P2860

Q26799231-37A6C46C-797A-4854-820D-59F1A089AE14 Q26828641-D9167FB5-6FAD-4AEA-8CA1-B4E3D53FA755 Q27311250-89CC03A8-D351-4A96-AE3E-FD5327060522 Q28276182-025535DB-5CC4-42C1-BF3D-1320E4C019C2 Q30535782-F0AB5D19-0D2F-4869-B6DD-BA4A4019C213 Q33566201-59887282-D8C0-4AD2-9DB4-17AA44D9BDF7 Q33934379-C2D85300-A6C0-4EDC-92CC-BFA962C216E3 Q33968846-2347CDE3-10A2-4A0A-AFEB-CD4AAC9B8A57 Q34122902-A02F2B61-09FF-4F3C-83F6-943611E8A4AD Q34270487-F53C076C-7677-4F46-8BB6-0FEF07EBA49E Q34376624-D1507DA3-58D0-44B5-B02D-1CDFAE2D48FB Q34385074-8DA77C85-6928-4742-9228-BD736E3F7FD0 Q34491601-1941F0B8-286D-4522-8E67-2C6C2C4F8DFE Q35744287-6818382A-7A0A-4D07-BF14-29806EB2EDCC Q35749136-05A24B95-B42E-4E9C-85BA-1E98E97A7B04 Q35871216-FDD91E31-6C70-4D70-8D53-17F076F17603 Q35917163-F07B994C-57F7-41A7-BC28-E59A18703552 Q36227275-F2B030D9-77B7-4B27-ACEC-65B0447AFB6D Q36441681-56180325-BA55-4EF1-BC00-7DF7366A2C6D Q36509367-95922C4F-E1CF-4C9F-9DF6-4A02EC789B0F Q36610017-B6100980-2E24-4FA2-A19D-A36981CB3F7D Q36621870-DD5AA978-CB3D-4076-A578-E507A9333A6A Q36977138-85564D89-BEDE-46F6-8757-5CFE21A5AAF7 Q36996570-F3A343A1-1071-42AD-9867-9BC728D2BE93 Q37226593-D4A06E2C-34EB-4829-82C1-D875196D0774 Q37226966-F0E5FD84-1EDD-436C-8C3A-79669789EF37 Q37310323-CBC34A1D-42A4-427F-B274-738A07E25525 Q37672302-64149354-2162-41BC-B9A2-6B5EF127D5F4 Q37718575-22A78E60-0C5A-4484-86D7-8C03F67AE605 Q37728569-BA358ACA-9C0C-4EF9-BAEA-85282A55DF2F Q37990357-2FA4756F-30B7-4798-BDC9-CD8A3BD19506 Q38169542-B61A0F0A-6CED-4E78-977F-1FF89CB2CFB3 Q38190773-A2CAB11A-28B6-4B0C-BBF0-4CEF28EC0CC5 Q38254814-C318C413-981E-422E-B847-B42F2CB69090 Q38274583-0F9E8FB8-34BE-4ED4-AC77-C4ABE881D4B9 Q38333687-04C6331A-0EA3-4DC3-BDC0-C2EC104D79D3 Q38788193-40C2E2D6-0122-436B-9AF1-5B00B5F80246 Q38850097-B196B7CF-693C-422E-9811-EBE0F57CD470 Q38947176-E645A67C-1ABF-4F0C-9D8B-CD3967CBDCA4 Q38978095-0C1E5878-8C72-45DC-BC3F-0C6D41188F40

P2860

Death following recreational use of designer drug "bath salts" containing 3,4-Methylenedioxypyrovalerone (MDPV).

http://www.wikidata.org/entity/Q36548946

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Death following recreational u ...... ylenedioxypyrovalerone (MDPV).

@ast

Death following recreational u ...... ylenedioxypyrovalerone (MDPV).

@en

type

label

Death following recreational u ...... ylenedioxypyrovalerone (MDPV).

@ast

Death following recreational u ...... ylenedioxypyrovalerone (MDPV).

@en

prefLabel

Death following recreational u ...... ylenedioxypyrovalerone (MDPV).

@ast

Death following recreational u ...... ylenedioxypyrovalerone (MDPV).

@en

P1433

Q36548946-5B6C0DF0-8042-48CD-AB8E-1663DA9800CA

P1476

Q36548946-55D43E37-4499-4B8C-A082-DAF42F2DAAB7

P2093

Q36548946-113CC057-1912-4FAE-9603-BDA552792BF6

Q36548946-14FC5B92-0032-4845-8176-83BE1D7441CC

Q36548946-894C9827-F1C4-45F7-895F-1A518FB97916

P2860

Q36548946-453EA4D3-03BB-4AD1-82B2-5680136463E2

Q36548946-4E6BEE30-A540-458A-AD90-30D79A229432

Q36548946-618D3348-85DD-45D0-82C7-43F0EEC2F2ED

Q36548946-6B2B08B5-E5EF-49BA-8947-60D845AECCBA

Q36548946-7013191B-0FB2-4810-82D9-1B73AF63EF1D

Q36548946-771E256A-ED3F-4DA8-B45C-F4557001282E

Q36548946-8294FE03-F810-4354-94F2-9AC915877408

Q36548946-8440E991-A533-4903-9CA3-E775E13F4C03

Q36548946-9AFA85D4-36DE-48FD-AFAC-3C544B91C9AD

Q36548946-A30E744E-02E9-492C-9493-887201631647

P2888

Q36548946-F245B529-104A-40C1-A302-572E0328B7FC

P304

Q36548946-2044EB30-5959-4988-B8D0-CFAE53087D16

P31

Q36548946-4A9F366D-5C75-4233-A15A-A968DCD4573F

Q36548946-6e850287-97b5-4686-8821-d3529b07ddfb

P356

Q36548946-A5B9B70D-490B-4C93-9134-CBC67C84BE35

P433

Q36548946-F7D81D56-4133-46F3-9F36-721383258E5D

P478

Q36548946-1A9C963C-3B6D-4FAA-BD94-75161BC1C587

P577

Q36548946-D072085C-6ED5-4938-B6CA-0D66CB75E645

P5875

Q36548946-BC6136DB-C86B-455A-BBCA-F3DDAEF2E656

P698

Q36548946-68812675-54F9-4F22-8327-9881848173EE

P932

Q36548946-212E3E28-AFF5-48A8-BE1D-48D725773877

P356

S13181-011-0196-9

P1433

Journal of Medical Toxicology

P1476

Death following recreational u ...... ylenedioxypyrovalerone (MDPV).

@en

P2093

Brittany L Murray

http://www.w3.org/2001/XMLSchema#string

Christine M Murphy

http://www.w3.org/2001/XMLSchema#string

Michael C Beuhler

http://www.w3.org/2001/XMLSchema#string

P2860

1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) analogues: a promising class of monoamine uptake inhibitors

Emergency department visits after use of a drug sold as "bath salts"--Michigan, November 13, 2010-March 31, 2011

Mass and NMR spectroscopic characterization of 3,4-methylenedioxypyrovalerone: a designer drug with alpha-pyrrolidinophenone structure

The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain

Toxicological determination and in vitro metabolism of the designer drug methylenedioxypyrovalerone (MDPV) by gas chromatography/mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry

Analysis of designer drugs detected in the products purchased in fiscal year 2006

Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS

Bath salts as a "legal high".

Experiences with mephedrone pre- and post-legislative controls: perceptions of safety and sources of supply.

Excited delirium

P2888

s13181-011-0196-9

P304

69-75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13181-011-0196-9

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221772066

http://www.w3.org/2001/XMLSchema#string

P698

22271565

http://www.w3.org/2001/XMLSchema#string

P932

3550226

http://www.w3.org/2001/XMLSchema#string